Pemphigus foliaceus worsened by drugs in a patient with psoriasis, responding to adalimumab
Pemphigus foliaceus is a blistering autoimmune disease related to the production of autoantibodies against desmoglein 1. We present a patient with psoriasis and pemphigus foliaceus aggravated by enalapril and amlodipine intake, with successful response of both conditions to adalimumab therapy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
---|---|
Enthalten in: |
Dermatology online journal - 23(2017), 10 vom: 15. Okt. |
Sprache: |
Portugiesisch |
---|
Beteiligte Personen: |
Sanz-Bueno, Jimena [VerfasserIn] |
---|
Themen: |
1J444QC288 |
---|
Anmerkungen: |
Date Completed 30.04.2018 Date Revised 18.07.2018 published: Electronic Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM281280169 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM281280169 | ||
003 | DE-627 | ||
005 | 20231225031253.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2017 xx |||||o 00| ||por c | ||
028 | 5 | 2 | |a pubmed24n0937.xml |
035 | |a (DE-627)NLM281280169 | ||
035 | |a (NLM)29469785 | ||
035 | |a (PII)13030/qt8tr4j1f2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a por | ||
100 | 1 | |a Sanz-Bueno, Jimena |e verfasserin |4 aut | |
245 | 1 | 0 | |a Pemphigus foliaceus worsened by drugs in a patient with psoriasis, responding to adalimumab |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 30.04.2018 | ||
500 | |a Date Revised 18.07.2018 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Pemphigus foliaceus is a blistering autoimmune disease related to the production of autoantibodies against desmoglein 1. We present a patient with psoriasis and pemphigus foliaceus aggravated by enalapril and amlodipine intake, with successful response of both conditions to adalimumab therapy | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
650 | 7 | |a Antihypertensive Agents |2 NLM | |
650 | 7 | |a Amlodipine |2 NLM | |
650 | 7 | |a 1J444QC288 |2 NLM | |
650 | 7 | |a Enalapril |2 NLM | |
650 | 7 | |a 69PN84IO1A |2 NLM | |
650 | 7 | |a Adalimumab |2 NLM | |
650 | 7 | |a FYS6T7F842 |2 NLM | |
700 | 1 | |a Gallo, Elena |e verfasserin |4 aut | |
700 | 1 | |a Caro-Gutiérrez, Dolores |e verfasserin |4 aut | |
700 | 1 | |a Sánchez-Gilo, Araceli |e verfasserin |4 aut | |
700 | 1 | |a Gutiérrez Pascual, Marta |e verfasserin |4 aut | |
700 | 1 | |a Rojas-Scheffer, Laura |e verfasserin |4 aut | |
700 | 1 | |a Vicente-Martín, Francisco Javier |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Dermatology online journal |d 1997 |g 23(2017), 10 vom: 15. Okt. |w (DE-627)NLM090971183 |x 1087-2108 |7 nnns |
773 | 1 | 8 | |g volume:23 |g year:2017 |g number:10 |g day:15 |g month:10 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 23 |j 2017 |e 10 |b 15 |c 10 |